Ignite Creation Date:
2024-05-06 @ 10:59 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03405584
Status:
COMPLETED
Last Update Posted:
2018-11-05
First Post:
2018-01-13
Brief Title:
High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment
Sponsor:
Shanghai Jiao Tong University School of Medicine
Organization:
Shanghai Jiao Tong University School of Medicine
Study Overview
Official Title:
Efficacy of High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatmenta Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dual therapy for Helicobacter Pylori including a proton pump inhibitor PPI and amoxicillin Amoxicillin has low resistance rate as well as low percentage of side effects No trial has examined the the efficacy of high dose of dual therapy plus bismuth for H pylori treatmentThis study is designed to evaluate the efficacy and safety of the addition of bismuth to high dose of dual therapy for H pylori eradication
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None